Shl Telemedicine Ltd (SHMLF) — 6-K Filings

6-K Filings (33)

• SHL Telemedicine Completes Rights Offering and Capital Increase — Dec 3, 2025 Risk: medium
  On December 3, 2025, SHL Telemedicine Ltd. announced the successful completion of its rights offering and capital increase. The company, headquartered at 90 Yig
• 6-K Filing — Nov 21, 2025
• SHL Telemedicine Shareholders Approve Share Capital Increase — Nov 20, 2025 Risk: low
  On November 20, 2025, SHL Telemedicine Ltd. announced that its shareholders approved an increase in the company's share capital. This decision was detailed in a
• SHL Telemedicine Calls Special General Meeting — Oct 30, 2025 Risk: low
  On October 30, 2025, SHL Telemedicine Ltd. announced an Invitation to a Special General Meeting. The purpose of this meeting is to discuss and vote on important
• SHL Telemedicine Ltd. Reports Special General Meeting Results — Sep 16, 2025 Risk: low
  On September 16, 2025, SHL Telemedicine Ltd. announced the results of its Special General Meeting. The company, headquartered at 90 Yigal Alon Street, Tel Aviv,
• SHL Telemedicine Announces 2025 Half-Year Results and Capital Raise — Sep 11, 2025 Risk: medium
  On September 11, 2025, SHL Telemedicine Ltd. announced its half-year results for 2025 and revealed plans for a capital raise. The company issued a press release
• SHL Telemedicine Calls Special General Meeting — Aug 12, 2025 Risk: low
  On August 12, 2025, SHL Telemedicine Ltd. announced an invitation to a Special General Meeting. The purpose of this meeting is to discuss and vote on important
• SHL Telemedicine Ltd. Holds Annual Shareholder Meeting — May 28, 2025 Risk: low
  On May 28, 2025, SHL Telemedicine Ltd. held its annual general meeting of shareholders. The meeting was previously described in a Notice and Proxy Statement fil
• SHL Telemedicine Clarifies Annual General Meeting Details — May 20, 2025 Risk: low
  On May 20, 2025, SHL Telemedicine Ltd. issued a press release to clarify information regarding its upcoming Annual General Meeting. The company provided this up
• SHL Telemedicine Ltd. Reports 2024 Annual Results — Apr 24, 2025 Risk: low
  On April 24, 2025, SHL Telemedicine Ltd. announced its 2024 annual results via a press release. The company also filed its audited consolidated Annual Report fo
• SHL Telemedicine Sets Annual Shareholder Meeting for May 28 — Apr 22, 2025 Risk: low
  SHL Telemedicine Ltd. announced on April 22, 2025, that its Annual General Meeting of Shareholders will take place on Wednesday, May 28, 2025, at 1:00 p.m. Isra
• SHL Telemedicine Discloses 2024 Write-Offs and Extraordinary Items — Apr 3, 2025 Risk: medium
  On April 3, 2025, SHL Telemedicine Ltd. announced write-offs and extraordinary items impacting its full-year 2024 results. The company issued a press release de
• SHL Telemedicine Files 6-K with SEC — Mar 24, 2025 Risk: low
  On March 24, 2025, SHL Telemedicine Ltd. announced the issuance of a press release. This report is a Form 6-K filing with the SEC, which is incorporated by refe
• SHL Telemedicine to Delist from Nasdaq, End ADR Program — Mar 11, 2025 Risk: medium
  On March 11, 2025, SHL Telemedicine Ltd. announced its intention to voluntarily delist from the Nasdaq Capital Market. The company also plans to terminate its A
• SHL Telemedicine Appoints New CFO — Feb 4, 2025 Risk: low
  SHL Telemedicine Ltd. announced on February 4, 2025, the appointment of Lior Haalman as its new Chief Financial Officer, effective March 1, 2025. This follows t
• SHL Telemedicine Elects New External Director — Dec 10, 2024 Risk: low
  On December 10, 2024, SHL Telemedicine Ltd. held a Special General Meeting of Shareholders where Orna Carni was elected as an external director for a three-year
• SHL Telemedicine Schedules Shareholder Meeting for Dec 10 — Nov 5, 2024 Risk: low
  SHL Telemedicine Ltd. announced on November 5, 2024, that a Special General Meeting of Shareholders will take place on December 10, 2024, in Tel Aviv, Israel. T
• SHL Telemedicine Ltd. Reports Half-Year 2024 Financial Results — Sep 26, 2024 Risk: low
  SHL Telemedicine Ltd. filed a Form 6-K on September 26, 2024, reporting its financial results for the half-year ended June 30, 2024. The filing includes a press
• SHL Telemedicine Ltd. Files Form 6-K with Press Release — Sep 24, 2024 Risk: low
  On September 24, 2024, SHL Telemedicine Ltd. announced the issuance of a press release, furnished as Exhibit 99.1 to this Form 6-K. This filing is incorporated
• SHL Telemedicine Ltd. Files Form 6-K with Press Release — Sep 19, 2024 Risk: low
  On September 19, 2024, SHL Telemedicine Ltd. issued a press release, furnished as Exhibit 99.1 to this Form 6-K. This filing is incorporated by reference into t
• SHL Telemedicine Ltd. Files 6-K with Press Release — Sep 5, 2024 Risk: low
  On September 5, 2024, SHL Telemedicine Ltd. announced the issuance of a press release. This Form 6-K filing incorporates that press release by reference into th
• SHL Telemedicine Appoints New Chairman — Sep 3, 2024 Risk: low
  SHL Telemedicine Ltd. announced on September 3, 2024, the immediate appointment of Dr. Itamar Offer as the new Chairman of the Board of Directors. This informat
• SHL Telemedicine Ltd. Files Form 6-K with SEC — Aug 26, 2024 Risk: low
  On August 26, 2024, SHL Telemedicine Ltd. announced the issuance of a press release. This Form 6-K filing is incorporated by reference into the Company's Regist
• SHL Telemedicine Ltd. Files Form 6-K with Press Release — Aug 2, 2024 Risk: low
  On August 2, 2024, SHL Telemedicine Ltd. issued a press release, furnished as Exhibit 99.1 to this Form 6-K. This filing is incorporated by reference into the c
• SHL Telemedicine Schedules Special Shareholder Meeting for Sept 5 — Jul 31, 2024 Risk: low
  SHL Telemedicine Ltd. announced on July 31, 2024, that a Special General Meeting of Shareholders will take place on September 5, 2024, at 5:00 p.m. Israel time.
• SHL Telemedicine Appoints New CEO — Jul 29, 2024 Risk: low
  SHL Telemedicine Ltd. announced on July 29, 2024, the appointment of David Arnon as its new Chief Executive Officer, effective August 6, 2024. This follows a pr
• SHL Telemedicine in Talks for Discount Capital Investment — Jun 20, 2024 Risk: medium
  On June 20, 2024, SHL Telemedicine Ltd. announced it is in discussions with Discount Capital Ltd., the investment arm of Israel Discount Bank, regarding a poten
• SHL Telemedicine Ltd. Shareholder Meeting Approves Compensation Policy — May 9, 2024 Risk: low
  On May 9, 2024, SHL Telemedicine Ltd. held a Special General Meeting of Shareholders where the Compensation Policy for Executive Officers and Directors was appr
• SHL Telemedicine Ltd. Reports 2023 Annual Results — Apr 17, 2024 Risk: low
  On April 17, 2024, SHL Telemedicine Ltd. announced its 2023 annual results via a press release and investor presentation. These documents, filed with the SEC as
• SHL Telemedicine Sets Shareholder Meeting for May 9 — Mar 26, 2024 Risk: low
  SHL Telemedicine Ltd. announced on March 26, 2024, that a Special General Meeting of Shareholders will be held on May 9, 2024, at 5:00 p.m. Israel time. The mee
• SHL Telemedicine Ltd. Files Form 6-K with Press Release — Mar 14, 2024 Risk: low
  On March 14, 2024, SHL Telemedicine Ltd. issued a press release, furnished as Exhibit 99.1 to this Form 6-K. This filing is incorporated by reference into the c
• SHL Telemedicine Shareholders Reject Board Expansion, Re-elect Directors — Feb 8, 2024 Risk: low
  SHL Telemedicine Ltd. held its annual general meeting on February 8, 2024, where shareholders voted on several key proposals. Notably, a proposal to increase th
• SHL Telemedicine Board Shake-Up: 4 Directors, Including Ehud Barak, Not Seeking Re-election — Feb 5, 2024
  SHL Telemedicine Ltd. announced on February 5, 2024, that four current board members—Erez Nachtomy, David Salton, Erez Alroy, and Co-Chairman Ehud Barak—will no

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX